197
Views
10
CrossRef citations to date
0
Altmetric
Article

The elemental changes occurring in the rat liver after exposure to PEG-coated iron oxide nanoparticles: total reflection x-ray fluorescence (TXRF) spectroscopy study

, , , , , , , & show all
Pages 1225-1236 | Received 08 Jun 2017, Accepted 19 Nov 2017, Published online: 29 Nov 2017

References

  • Babadi, Y., L. Najafi, A. Najafi, H. Gholami, M. Ebrahim, B. Zarji, J. Golzadeh, E. Amraie, A. Shirband, and P. D. Candidate. 2012. “Evaluation of Iron Oxide Nanoparticles Effects on Tissue and Enzymes of Liver in Rats.” Journal of Pharmaceutical and Biomedical Sciences 23 (23): 1–5.
  • Baratli, Y., A. L. Charles, V. Wolff, L. Ben Tahar, L. Smiri, J. Bouitbir, J. Zoll, et al. 2014. “Age Modulates Fe3O4 Nanoparticles Liver Toxicity: Dose-Dependent Decrease in Mitochondrial Respiratory Chain Complexes Activities and Coupling in middle-Aged as Compared to Young Rats.” BioMed Research International 2014: 1–10.
  • Bennun, L., and V. Sanhueza. 2010. “A Procedure for the Improvement in the Determination of a TXRF Spectrometer Sensitivity Curve.” Analytical Sciences 26 (3): 331–335.
  • Bruker. 2008. S2 Picofox TM User Manual. Berlin: Bruker AXS Microanalysis GmbH This.
  • Chertok, B., B. A. Moffat, A. E. David, F. Yu, C. Bergemann, B. D. Ross, and V. C. Yang. 2008. “Iron Oxide Nanoparticles as a Drug Delivery Vehicle for MRI Monitored Magnetic Targeting of Brain Tumors.” Biomaterials 29 (4): 487–496.
  • Corot, C.,. P. Robert, J. M. Idée, and M. Port. 2006. “Recent Advances in Iron Oxide Nanocrystal Technology for Medical Imaging.” Advanced Drug Delivery Reviews 58 (14): 1471–1504.
  • Dhawan, A., and V. Sharma. 2010. “Toxicity Assessment of Nanomaterials: Methods and Challenges.” Analytical and Bioanalytical Chemistry 398 (2): 589–605.
  • Dobson, J. 2006. “Magnetic Nanoparticles for Drug Delivery.” Drug Development Research 67 (1): 55–60.
  • Eid, C., M. Hémadi, N. T. Ha-Duong, and J. M. El Hage Chahine. 2014. “Iron Uptake and Transfer from Ceruloplasmin to Transferrin.” Biochimica Et Biophysica Acta 1840 (6): 1771–1781.
  • Eid, R., N. T. T. Arab, and M. T. Greenwood. 2017. “Iron Mediated Toxicity and Programmed Cell Death: A Review and a Re-Examination of Existing Paradigms. Biochimica Et Biophysica Acta.” Biochimica Et Biophysica Acta 1864 (2): 399–430. ”
  • Ermak, G., and K. J. Davies. 2002. “Calcium and Oxidative Stress: From Cell Signaling to Cell Death.” Molecular Immunology 38 (10): 713–721.
  • Fadeel, B., and A. E. Garcia-Bennett. 2010. “Better Safe than Sorry: Understanding the Toxicological Properties of Inorganic Nanoparticles Manufactured for Biomedical Applications.” Advanced Drug Delivery Reviews 62 (3): 362–374.
  • Fischer, H. C., and W. C. Chan. 2007. “Nanotoxicity: The Growing Need for in Vivo Study.” Current Opinion in Biotechnology 18 (6): 565–571.
  • Fujikura, Y., J. Krijt, C. Povýšil, Z. Mělková, P. Přikryl, M. Vokurka, and E. Nečas. 2016. “Iron Overload Causes Alterations of E-Cadherin in the Liver.” Folia Biologica (Praha) 62 (3): 95–102.
  • Fukai, T., and M. Ushio-Fukai. 2011. “Superoxide Dismutases: role in Redox Signaling, Vascular Function, and Diseases.” Antioxidants & Redox Signaling 15 (6): 1583–1606.
  • Grieken, R. E., and A. A. Markowicz. 2001. Handbook of X-Ray Spectrometry. New York, Basel, Hong Kong: Marcel Dekker, Inc.
  • Hanini, A., A. Schmitt, K. Kacem, F. Chau, S. Ammar, and J. Gavard. 2011. “Evaluation of Iron Oxide Nanoparticle Biocompatibility.” International Journal of Nanomedicine 6: 787–794.
  • Harris, E. D. 2001. “Copper Homeostasis: The Role of Cellular Transporters.” Nutrition Reviews 59 (9): 281–285.
  • Hurst, S., J. Hoek, and S.-S. Sheu. 2016. “Mitochondrial Ca2+ and Regulation of the Permeability Transition Pore.” Journal of Bioenergetics and Biomembranes 1: 1–21.
  • Hussain, S. M., K. L. Hess, J. M. Gearhart, K. T. Geiss, and J. J. Schlager. 2005. “In Vitro Toxicity of Nanoparticles in BRL 3A Rat Liver Cells.” Toxicology in Vitro : An International Journal Published in Association with Bibra 19 (7): 975–983.
  • Jain, T. K., J. Richey, M. Strand, D. L. Leslie-Pelecky, C. A. Flask, and V. Labhasetwar. 2008. “Magnetic Nanoparticles with Dual Functional Properties: drug Delivery and Magnetic Resonance Imaging.” Biomaterials 29 (29): 4012–4021.
  • Jain, T. K., M. K. Reddy, M. A. Morales, D. L. Leslie-Pelecky, and V. Labhasetwar. 2008. “Biodistribution, Clearance, and Biocompatibility of Iron Oxide Magnetic Nanoparticles in Rats.” Molecular Pharmaceutics 5 (2): 316–327.
  • De Jong, W. H., and PJ. a. Borm. 2008. “Drug Delivery and Nanoparticles:applications and Hazards.” International Journal of Nanomedicine 3 (2): 133–149.
  • Kubala-Kukuś, A., D. Banaś, J. Braziewicz, U. Majewska, and M. Pajek. 2003a. “Comparative Study of Trace Element Contents in Human Full-Term Placenta and Fetal Membranes by Total Reflection X-Ray Fluorescence.” Spectrochimica Acta – Part B Atomic Spectroscopy 58 (4): 725–734.
  • Kubala-Kukuś, A., D. Banaś, J. Braziewicz, U. Majewska, and M. Pajek. 2003b. “Concentration Distribution of Trace Elements: From Normal Distribution to Lévy Flights.” Spectrochimica Acta Part B: Atomic Spectroscopy 58 (4): 717–724.
  • Limón-Pacheco, J., and M. E. Gonsebatt. 2009. “The Role of Antioxidants and Antioxidant-Related Enzymes in Protective Responses to Environmentally Induced Oxidative Stress.” Mutation Research/Genetic Toxicology and Environmental Mutagenesis 674 (1–2): 137–147.
  • Mody, V. V., A. Cox, S. Shah, A. Singh, W. Bevins, and H. Parihar. 2014. “Magnetic Nanoparticle Drug Delivery Systems for Targeting Tumor.” Applied Nanoscience 4 (4): 385–392.
  • Magaye, R. R., X. Yue, B. Zou, H. Shi, H. Yu, K. Liu, X. Lin, et al. 2014. “Acute Toxicity of Nickel Nanoparticles in Rats after Intravenous Injection.” International Journal of Nanomedicine 9: 1393–1402.
  • Pankhurst, Q. A., J. Connolly, S. K. Jones, and J. Dobson. 2003. “Applications of Magnetic Nanoparticles in Biomedicine.” Journal of Physics D: Applied Physics 36 (13): R167–R181.
  • Parivar, K., F. Malekvand Fard, M. Bayat, S. M. Alavian, and M. Motavaf. 2016. “Evaluation of Iron Oxide Nanoparticles Toxicity on Liver Cells of BALB/c Rats.” Iranian Red Crescent Medical Journal 18 (1),: 5.
  • Potočnik, J. 2011. Commission Rcommendation of 18 October 2011 on the Definition of Nanomaterial. Official Journal of the European Union. http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32011H0696
  • Roeser, H. P., G. R. Lee, S. Nacht, and G. E. Cartwright. 1970. “The Role of Ceruloplasmin in Iron Metabolism.” The Journal of Clinical Investigation 49 (12): 2408–2417.
  • Sayes, C. M., K. L. Reed, and D. B. Warheit. 2007. “Assessing Toxicology of Fine and Nanoparticles: Comparing in Vitro Measurements to in Vivo Pulmonary Toxicity Profiles.” Toxicological Sciences 97 (1): 163–180.
  • Shaheen, M., Y. Cheema, A. U. Shahbaz, S. K. Bhattacharya, and K. T. Weber. 2011. “Intracellular Calcium Overloading and Oxidative Stress in Cardiomyocyte Necrosis via a Mitochondriocentric Signal-Transducer-Effector Pathway.” Experimental and Clinical Cardiology 16 (4): 109–115.
  • Sharma, A., S. V. Madhunapantula, and G. P. Robertson. 2012. “Toxicological Considerations When Creating Nanoparticle Based Drugs and Drug Delivery Systems?” Expert Opin Drug Metab Toxicol 8 (1): 47–69.
  • Sun, C., J. S. H. Lee, and M. Zhang. 2008. “Magnetic Nanoparticles in MR Imaging and Drug Delivery.” Advanced Drug Delivery Reviews 60 (11): 1252–1265.
  • Tomeckova, V., E. Barnova, J. Guzy, Z. Chavkova, M. Marekova, K. Dubayova, and J. Kusnir. 2000. “Fe2+-Induced Oxidative Processes in the Liver Mitochondria of Rats.” Bratisl Lek Listy 101 (4): 213–218.
  • Valko, M., D. Leibfritz, J. Moncol, M. T. Cronin, M. Mazur, and J. Telser. 2007. “Free Radicals and Antioxidants in Normal Physiological Functions and Human Disease.” The International Journal of Biochemistry & Cell Biology 39 (1): 44–84.
  • Valko, M., C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur. 2006. “Free Radicals, Metals and Antioxidants in Oxidative Stress-Induced Cancer.” Chemico-Biological Interactions 160 (1): 1–40.
  • Varallyay, P., G. Nesbit, L. L. Muldoon, R. R. Nixon, J. Delashaw, J. I. Cohen, A. Petrillo, D. Rink, and E. A. Neuwelt. 2002. “Comparison of Two Superparamagnetic Viral-Sized Iron Oxide Particles Ferumoxides and Ferumoxtran-10 with a Gadolinium Chelate in Imaging Intracranial Tumors.” American Journal of Neuroradiology 23 (4): 510–519.
  • Wierzbicka, D., and G. Gromadzka. 2014. “Ceruloplasmin, Hephaestin and Zyklopen: The Three Multicopper Oxidases Important for Human Iron Metabolism]. Postępy Higieny i Medycyny Doświadczalnej.” Postępy Higieny i Medycyny Doświadczalnej 68: 912–924.
  • Wobrauschek, P. 2007. “Total Reflection x-Ray Fluorescence Analysis – A Review.” X-Ray Spectrometry 36 (5): 289–300.
  • Wróbel, P. M., S. Bała, M. Czyzycki, M. Golasik, T. Librowski, B. Ostachowicz, W. Piekoszewski, A. Surówka, and M. Lankosz. 2017. “Combined Micro-XRF and TXRF Methodology for Quantitative Elemental Imaging of Tissue Samples.” Talanta 162: 654–659.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.